Efficacy of water-soluble analogs of vitamin E in the prevention of myocardial ischemia-reperfusion injury.
Mickle
D A
DA
Department of Clinical Biochemistry, Toronto Hospital, University of Toronto, Ontario, Canada.
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D002478:Cells, Cultured; D002839:Chromans / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004727:Endothelium / Q000166:cytology / Q000187:drug effects; D006801:Humans; D010743:Phospholipids / Q000032:analysis; D011817:Rabbits; D051381:Rats; D015427:Reperfusion Injury / Q000175:diagnosis / Q000517:prevention & control*; D012508:Sarcolemma / Q000187:drug effects; D012995:Solubility; D014810:Vitamin E / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use*
D000975:Antioxidants; D002839:Chromans; D010743:Phospholipids; D014810:Vitamin E; C010643:6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid